BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4146398)

  • 1. Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.
    Corrodi H; Fuxe K; Hökfelt T; Lidbrink P; Ungerstedt U
    J Pharm Pharmacol; 1973 May; 25(5):409-12. PubMed ID: 4146398
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 3. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of prostaglandin E 2 on central and peripheral catecholamine neurons.
    Bergström S; Farnebo LO; Fuxe K
    Eur J Pharmacol; 1973 Mar; 21(3):362-8. PubMed ID: 4145320
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.
    Hökfelt T; Fuxe K
    Neuroendocrinology; 1972; 9(2):100-22. PubMed ID: 5061810
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
    [No Abstract]   [Full Text] [Related]  

  • 8. Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation.
    Fuxe K; Corrodi H; Hökfelt T; Lidbrink P; Ungerstedt U
    Med Biol; 1974 Apr; 52(2):121-32. PubMed ID: 4837435
    [No Abstract]   [Full Text] [Related]  

  • 9. [The brain catecholamine systems in the regulation of dominance].
    Serova LI; Naumenko EV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(3):490-6. PubMed ID: 1975967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 6-hydroxydopamine and alpha-methyl-para-tyrosine on the acoustic startle response in rats.
    Sorenson CA; Davis M
    Pharmacol Biochem Behav; 1975; 3(3):325-9. PubMed ID: 1153437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.
    Corrodi H; Farnebo LO; Fuxe K; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1972 Nov; 20(2):195-204. PubMed ID: 4651208
    [No Abstract]   [Full Text] [Related]  

  • 12. Evoked potential studies of brain catecholamine alterations in monkeys.
    Redmond DE; Borge GF; Buchsbaum M; Maas JW
    J Psychiatr Res; 1975 Aug; 12(2):97-116. PubMed ID: 808601
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.
    Fuxe K; Holmstedt B; Jonsson G
    Eur J Pharmacol; 1972 Jul; 19(1):25-34. PubMed ID: 4403108
    [No Abstract]   [Full Text] [Related]  

  • 15. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines.
    Gasull T; Giralt M; Garcia A; Hidalgo J
    Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine depletion produces irrepressible saccadic eye movements in normal humans.
    Tychsen L; Sitaram N
    Ann Neurol; 1989 May; 25(5):444-9. PubMed ID: 2570547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of catecholamines in the regulation of pituitary luteinizing hormone and follicle-stimulating hormone secretion.
    Barraclough CA; Wise PM
    Endocr Rev; 1982; 3(1):91-119. PubMed ID: 6120832
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of LHRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Nasello AG; Bydlowski CR; Felicio LF
    Pharmacol Biochem Behav; 1990 Dec; 37(4):639-42. PubMed ID: 1982693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of central effects of 6-aminodopamine and 6-hydroxydopamine on catecholamine levels.
    Oke A; Freeman R; Adams RN
    Eur J Pharmacol; 1974 Apr; 26(1):125-7. PubMed ID: 4831981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.